Sab Biotherapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sab Biotherapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $175 | 87 | 2.01 |
| 2025-03-31 | $138 | 103 | 1.34 |
| 2024-12-31 | $402 | 105 | 3.83 |
| 2024-09-30 | $284 | 106 | 2.68 |
| 2024-06-30 | $329 | 106 | 3.11 |
| 2024-03-31 | $472 | 104 | 4.54 |